Biotech: Page 36

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies By Carolyn Gretton Clinical Force Acquisition Strengthens Medidata’s CTMS Offerings Trends: E-clinical solutions providers continue to bolster their clinical trial management solutions (CTMS) offerings as demand surges amid increa...

    By Carolyn Gretton • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2011 PharmaVOICE 100 - Who's on the List by Section

    The Commanders & Chiefs Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer C...

    By PharmaVoice Team • July 26, 2011
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Commanders & Chiefs

    Frank Baldino Jr., Ph.D.    Cephalon Inc. Donna Beardsworth.    Beardsworth Group Calep A. (Joe) Boyd III    MCS Healthcare Public Relations Randall Carpenter, M.D.     Seaside Therapeutics N. Anthony Coles, M.D.    Onyx Pharmaceuticals B. Reid Connolly    evoke interaction Donna Cryer    CryerHe...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Damian BRAGA Sanofi Pasteur Consolidates ­Commercial Operations Leadership Sanofi Pasteur, the vaccines division of global healthcare company Sanofi, has tapped U.S. President Damian Braga as s...

    By Carolyn Gretton • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    August 6-8 BIT’s 1st Annual World Congress of Molecular & Cell Biology Beijing International Convention Center, Beijing BIT Life Sciences, http://www.bitlifesciences.com/cmcb2011/ August 8-9 Development and Validation of ­Bioanalytical Assays for Biologics: Quantitation (PK) and Immunogenicit...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New healthcare-related products, services, and companies By Carolyn Gretton PPD Expands Product Development Consulting Services Trend: Quick growth in sectors like biosimilars and adaptive trial design have life-sciences ­companies clamoring for consultants with specific knowledge of t...

    By Carolyn Gretton • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2011 PharmaVOICE 100 - Who's on the List by Company

    Acorda Therapeutics Andrew Blight, Ph.D. ACT Biotech Inc. Ali Fattaey, Ph.D. Acucela Inc. Ryo Kubota, M.D., Ph.D. Alliance Healthcare Information LLC Mary Anne Greenberg Almac Group Sir Allen McClay The Avoca Group Inc. Patricia Leuchten AXON US Mario Nacinovich Beardsworth Group Donna Beardswort...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Taking Inspiration to the Next Level This is our favorite issue of the year, and we hope it’s yours too. It has been a joy and a privilege to have had a chance to get to know this year’s PharmaVOICE 100. They certainly illustrate what it means to think bigger, do more, and lead with passion and i...

    By Taren Grom • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: A Changing Rhythm

    According to Barbara Wirostko, M.D., chief medical officer for Altheos, the question of whether a product candidate will be reimbursed by government and third-party payers is now surfacing in the earliest stages of discovery. “Because there are now issues around who is going to reimburse and who ...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Educating the Scientists of the Future

    High-quality science education is critical for the success of pharmaceutical and biotechnology companies, not only to meet the need for scientists in the future but also to foster scientific ­literacy. Education reform is a hot-button issue for the nation in general and the pharmaceutical industr...

    By Denise Myshko • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA Preview

    New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by ­companies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Combating Drug Resistance Roger Pomerantz, M.D., Senior VP and Head of Infectious Disease Research at Merck, talks about why antimicrobial resistance is a major global concern. PV: How big of a problem is antimicrobial ­resistance? Pomerantz: For the first time since the antibiotic era started in...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Janet HAMMOND Roche Strengthens Translational Medicine Leadership Roche has appointed Janet Hammond, M.D., Ph.D., VP, translational medicine – virology in pharmaceutical research and early development (pRED). Dr. Hammond joins Roche from Valeant Pharmaceuticals Internation...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Ahn Nyeong: South Korea Emerges

    In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...

    By Kim Ribbink • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Partnering for Diagnostics

    Molecular diagnostics, one of the fastest growing segments in the diagnostics market, are key enablers in delivering personalized medicine. According to industry consultants, molecular diagnostics are set to become the dominant platform in clinical medicine. But currently only about 10% of labels...

    By Denise Myshko • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating a Personalized Medicine Strategy

    Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...

    By Denise Myshko • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    America’s biopharmaceutical ­research companies invested a record $67.4 billion last year in R&D, an increase of $1.5 billion. Healthcare Providers Say Pharma Provides Value Almost 8 out of 10 physicians view pharmaceutical companies and their sales reps as useful sources of information on ­m...

    By PharmaVoice Team • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The mHealth Revolution The Statistics are staggering. According to a report by research2guidance, by 2015 one in five people around the world will have a smartphone. Another report states that mobile app revenue is expected to reach $35 billion by 2014. Finally, company investment in mobile phone...

    By Taren Grom • April 25, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Era of Biosimilars

    Although healthcare reform paved the way for a regulatory pathway for biosimilars, the ­biopharmaceutical industry is facing a world of uncertainty as developers and regulators ­navigate their way through this shifting ­landscape. Biosimilar Defined » A “biosimilar" is a biological product that i...

    By Denise Myshko • March 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Privyet! Russia: Growth and Opportunity

    With its promise of expansion, its population of around 140 million potential customers, and a pool of highly qualified staff, Russia has long been recognized as an important market for pharmaceutical companies. The pharma market in Russia has shown stable annual growth of 13% to 20% for several ...

    By Kim Ribbink • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Steve FRY Dr. Sue MAHONY Lilly Announces Leadership Shifts Lilly has promoted Steve Fry to senior VP of human resources and diversity. Mr. Fry was previously VP of human resources for two of Lilly’s business areas, biomedicines and emerging markets. Mr. Fry succeeds Sue Mahony...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    » Scott Weintraub Honored Scott Weintraub, founding ­principle of Healthcare ­Regional Marketing, has been selected for the 2010 ­Outstanding Leadership ­Recognition Award by the U.S. ­Leaders and Entrepreneur’s ­Association (USLEA). The USLEA Awards Program recognizes highly regarded individuals...

    By PharmaVoice Team • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    The Price of Success THE COST OF INNOVATION. The recent article published in the Feb. 7, 2011, issue of the journal BioSocieties for The London School of Economics and Political Science is causing quite a stir. The authors — Donald W. Light of Stanford University and University of Medicine and De...

    By Taren Grom • March 28, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Thought Leaders

    Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academ...

    By PharmaVoice Team • March 7, 2011